Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71061 | DSM267 | ||
DSM267 is a novel Plasmodium falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitor. | |||
T71969 |
Remacemide
|
||
Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. |